ABSTRACT. Subfraction 2R of fraction 9 from a peptictryptic-pancreatic digest of wheat gliadin is known to be toxic in vivo to celiac patients. We have found that fractions 9 and 2R inhibit the in vitro development of fetal rat intestine and the increase of enterocyte height occurring in organ culture of atrophic celiac mucosa (0.1-0.5 mg/ml medium). Other peptide fractions of the gliadin digest are devoid of such in vitro effects. Subfraction ZR, after incubation with morphologically normal small intestinal mucosa of celiacs in remission and ultrafiltration, was still very active in both culture systems at low concentration (0.1 mg/ml); on the contrary, subfraction 2R was inactivated after incubation with normal mucosa. These results are compatible with the hypothesis that there is a mucosal defect in handling gliadin peptides in celiac disease, and suggest that there is either a primary (or secondary) enzyme deficiency or some other mechanism operating in the intestinal mucosa of celiac patients in remission. (Pediatr Res 24: 233-237,1988) Abbreviation PTC, peptic-tryptic-cotazym
that are toxic in celiac disease. Gliadin and prolamin peptides from cereals that are toxic in celiac disease (wheat, rye, barley, and oats) are very active in inhibiting in vitro development and morphogenesis of small intestine from 17-day-old rat fetuses (22, 23) .
Cornell and Townley (24) fractionated a peptic-tryptic-pancreatic digest of gliadin into 10 primary fractions by chromatography on S.P. Sephadex. Fraction 9 of this digest is the most active in causing significant reduction in D-xylose absorption in celiac patients in remission (25) , preventing the morphological recovery of the epithelium of the atrophic intestinal mucosa of celiac patients (26) and inhibiting the in vitro development and differentiation of the fetal rat intestine (22) .
Subfractions 1 and 2, obtained by QAE Sephadex chromatography of fraction 9, and the purified forms 9-1B and 9-2B also have been shown to decrease the urinary excretion of xylose when fed to celiac patients in remission (27) . Fraction 9 and subfractions 1 and 2 also were the only ones that were incompletely digested by histologically normal celiac mucosa and by mucosa of first degree relatives of celiac patients when compared to digestion by mucosa of normal controls (24, 27, 28) , suggesting a primary mucosal defect in celiac disease (28) .
The aim of our study was to evaluate the capability of the peptide fractions 9 and (subfraction) 2R to inhibit the in vitro development of the fetal rat intestine and the morphological recovery of cultured atrophic celiac mucosa before and after normal digestion of the fractions with recovered celiac mucosa and normal mucosa.
MATERIALS AND METHODS
Preparation of gliadin peptides. Gliadin (BDH, U.K.), prepared from the wheat variety "Capella Desprez," was used for the preparation of the digests. PTC digests were prepared by treatment of the gliadin with each of the enzymes in succession and the final digests adjusted to pH 3.1 and centrifuged as described previously by Cornell and Townley (24) . The PTC digests were fractionated on S.P. Sephadex (C-25) into 10 major peptide fractions as previously described (24) . Subfractions of fraction 9 were prepared on QAE Sephadex A-25 as described previously (24, 28) . Briefly, this involved the application of fraction 9 (400 mg) to a column (23 x 1.4 cm) of QAE Sephadex equilibrated in 0.02 M Tris-citrate buffer, pH 9.2. Subfraction 1 was eluted in the starting buffer and subfraction 2 was then eluted on application of a 0.02 M Tris-citrate buffer of pH 6.0. The lyophilized subfraction 2 was desalted on Biogel P-2 (BioRad Laboratories, Richmond, CA) and again lyophilized. The major components of these subfractions have an apparent mol. ~t .
of 1400-1500 (28). Subfraction 2 of fraction 9 was incubated with remission celiac mucosa at 37" C and pH 7.5 for 2 h after which it was heated to 60" C for 5 min and ultrafiltered using "Centriflo" CF 50 membrane cones (Amicon Corp., Redwood City, CA) as reported previously (24) . The concentration of the peptides and amino acids remaining after digestion were measured by the microKjeldahl method.
In vitro culture of fetal rat intestine. Pregnant Wistar rats were anesthetized with ether and 17-day-old fetuses were removed at laparotomy. Fetal jejunum segments were isolated and cultured in vitro for 48 h in a serum-free medium according to the method described by de Ritis et al. (29) . Jejunal segments from the same fetus were cultured in the absence and presence of the peptides. All the peptide mixtures were sterilized before addition to incubation medium by filtration through 0.22 mp Millipore filters. Differentiation of the fetal rat jejunuin was followed morphologically by light microscopy as reported by de Ritis et al. (29) without knowledge of the culture conditions.
A morphological assessment of histological changes during organ culture of 17-day-old fetus intestine was performed on the more external part of the tissue where the epithelium more clearly showed developmental changes in the absence of gliadin peptides. In this part of the tissue specimen we constantly observed wellformed villi that do not develop in the more internal part of the intestinal segment probably as the consequence of the more dificult penetration of the tissue by the culture medium. The first five sections were cut off and the next 10-20 sections were evaluated. No appreciable variations in the developmental pattern of intestinal mucosa were observed among these histological sections.
In vitro culture of human small intestinal mucosa. Intestinal biopsies were obtained at the duodenojejunal flexure from 1 I children affected by active celiac disease with subtotal mucosal atrophy. Diagnosis of celiac disease was based on the presence of clinical malabsorption and typical histological lesions of intestinal mucosa, both of which healed after several months on a gluten-free diet. The small intestinal lesions relapsed after introduction of gluten into the diet.
The tissue was cultured for 30 h in a serum-containing medium, without and with added peptide fractions, according to the method of Browning and Trier (30) as modified by Jos et al. (14) . Just after their excision and after 30 h in culture, biopsy specimens were fixed in 10% formol, dehydrated, embedded in paraffin, and serially sectioned. Changes in enterocyte height during culture were used as a marker of toxicity. These were measured according to Howdle et al. (20) without knowledge of the culture conditions. At least 20 enterocytes were measured in each section and the mean enterocyte height was calculated for each section.
RESULTS
In vitro culture of fetal rat intestine. Before culture, the jejunal mucosa of 17-day-old fetuses showed only undifferentiated cuboidal stratified epithelial cells lining the lumen; there were no villi. No goblet cells could be detected in any of the uncultured fetuses (Table I ; Fig 1A) . After 48 h of in vitro culture in the absence of gliadin peptides (Table 1 ; Fig. 1 B) , well-formed villi were present in 17 fetal jejunum segments and rudimentary villi were observed in jejunal segments from only one fetus.
In all cultured segments the epithelial lining consisted exclusively of simple columnar epithelium and in seven cases goblet cells were detected. Patchy, slight degenerative changes were observed only in a few cultured jejuna from five fetuses. These results confirm previous results by de Ritis et al. (29) showing that differentiation and maturation of small intestinal mucosa from rat fetus take place in vitro in a way comparable to in vivo differentiation.Fractions 1 and 5 did not affect in vitro differentiation of fetal rat jejunum, even when tested at a concentration as high as 0.5 mg/ml. At this concentration, fraction 9 and subfraction 2R were able to inhibit in vitro development of fetal rat intestine and to increase occurrence and severity of degener- ative changes (Table 1) . Such effects were clearly observed at a concentration as low as 0.1 mg/ml. Subfraction 2R after digestion by intestine from patients affected by celiac disease remains very active in slowing down in vitro development of fetal rat intestine and in increasing the prevalence and severity of degenerative changes, whereas the toxicity of the same fraction after digestion by the intestine of normal subjects is absent or almost absent even at the highest tested concentration (0.5 mg/ml). Well-differentiated villi were absent in six of eight cultures and were rudimentary in the remaining two cultures in the presence of 0.1 mg/ml of 2R after celiac digestion (Table 1 ; Fig. 1 C) ; villi were, on the contrary, well developed in six of seven cultures in the presence of the same quantity of 2R after normal digestion, and goblet cells were present in three cultures (Table 1 ; Fig. 1 D) .
In vitro culture of human small intestinal mucosa. Before in Fig. 2 . Effect of the subfraction 2R after digestion by histologically normal celiac mucosa and normal mucosa from controls on in vitro culture of jejunal biopsy specimens from children with untreated celiac disease. A, jejunal mucosa before culture. A total loss of villous pattern with cuboidal and irregular epithelial cells is evident. B, jejunal mucosa after 30 h of culture in the presence of subfraction 2R after digestion by histologically normal celiac mucosa (0.1 mg/ml). The tissue does not show any improvement. The surface epithelium is damaged and degenerative changes are evident. C, jejunal mucosa after 30 h of culture in the presence of subfraction 2R after digestion by histologically normal mucosa from normal controls (0.1 mg/ml). The morphological abnormalities of the surface epithelium have almost completely disappeared showing recovery of the surface epithelium cells that are taller and more regular.
ET AL.
vitro culture all the small intestinal biopsy specimens from children with active celiac disease showed a flat mucosa with total loss of villous pattern and with elongated hypertrophic crypts. The surface epithelium showed cuboidal cells with irregular nuclei, and the enterocyte height was decreased (Table 2 ; Fig. 2A) . After 30 h culture in the absence of gliadin peptides all these biopsies showed significant recovery; the enterocyte was taller with basically oriented nuclei. Biopsy specimens did not recover when cultured in the presence of subfraction 2R (0.1 mg/ml) before and after incubation with celiac mucosa, whereas the same subfraction after incubation with normal mucosa (0.1 mg/ml) did not inhibit epithelial recovery occurring after 30 h culture (Table 2 ; Fig. 2B and C) . DISCUSSION In our study we have demonstrated that fraction 9 and its subfraction 2R, obtained from a peptic-tryptic-pancreatic digest of bread wheat gliadin are very active in inhibiting in vitro development of fetal rat intestine. Subfraction 2R also is able to prevent in vitro morphological recovery of the enterocytes of atrophic celiac mucosa. The other fractions tested were less active or not active in these in vitro systems. The results therefore confirm previously published findings (22, 24) . The activity of gliadin peptides in the various in vitro systems we use appears to be in some way related to the in vivo toxicity in celiac disease, as the same fractions 9 and 2R have been shown to contain a large proportion of gliadin peptides that are toxic in vivo to celiac patients.
Previous studies of Cornell and Rolles (28) have demonstrated that fraction 9 and subfractions 1R and 2R are the only ones that were incompletely digested by remission celiac mucosa when compared to digestion with mucosa from normal controls. The major aim of the present study was to determine whether there is some difference between celiac and control mucosa regarding the ability to detoxify the in vitro and in vivo toxic subfraction 2R. The peptides of subfraction 2R remaining after digestion with histologically normal celiac mucosa were still able to inhibit the in vitro development of fetal rat intestine and to prevent in vitro recovery of enterocytes of atrophic celiac mucosa, whereas these activities were absent after digestion of the same peptide fraction with normal mucosa.
These results suggest that celiac mucosa is not able to detoxify the gliadin peptide fractions which are toxic for celiac patients and are compatible with the hypothesis that there is some mucosal defect in celiac disease. However, whether these in vitro studies apply to the in vivo situation is unknown. Definitive proof of this hypothesis should be confirmed by further studies. One possible way would be to identify the structure of one (or more) of the in vitro toxic peptides remaining after digestion with celiac mucosa and to obtain large amounts by synthesis of this peptide(s) for further in vivo studies.
The nature of the defect of celiac mucosa in handling in vitro the 2R gliadin fraction in unknown. This may be due to lack in celiac mucosa of a specific enzyme involved in digestion of these particular gliadin peptides. It has been demonstrated (31) that the pattern of gliadin digestion by normal and celiac mucosa is basically the same, and that the activities of various digestive peptidases are normal or almost normal in histologically normal intestinal mucosa of celiac patients. Nevertheless, the possibility that an enzyme different from those tested up to now is lacking in celiac mucosa is not yet completely disproved. The enzymatic deficiency could be primary or secondary to the celiac disease. The mucosa we used for digestion of subfraction 2R is histologically within normal limits, and disaccharidase activities were also found to be normal, suggesting that the mucosal defect, if present, could be primary. The possibility also remains that the mucosal defect is secondary, as there will always be doubt whether the tissue has completely recovered or whether the gliadin-free diet on which the patients are placed may influence some enzymatic activities of the intestine. It is known that the activity of the aminopeptidase A (31) remains low in celiac mucosa in remission. The defect of celiac mucosa in handling some gliadin peptides may not be due to an enzyme deficiency. For example, a decreased binding to the celiac mucosa of gliadin peptides as compared with normal mucosa could also explain our results, as we have studied, in the various in vitro systems, only the peptides that are present in the ultrafiltrates of the incubation mixtures.
